Ivan Bergstein, Chief Executive Officer at STEMLINE THERAPEUTICS INC (STML), sold 68,264 shares at $10.98 ($750K) on 2019-02-14, disclosed to the SEC on 2019-02-15.
Seasonal sale ($750k) by Chief Executive Officer — this insider has traded STML in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.98 | 34,132 | $375K | 50.0% |
| 2 | $10.98 | 34,132 | $375K | 50.0% |
| Total | $10.98 avg | 68,264 | $750K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $316K | — | Filing → |
| STML | SELL | 2020-01-03 | $987K | — | Filing → |
| STML | SELL | 2019-08-16 | $1.0M | — | Filing → |